Mapping of a Ligand-binding Site for the Human Thromboxane A2 Receptor Protein
Open Access
- 1 May 2002
- journal article
- Published by Elsevier
- Vol. 277 (19) , 16791-16797
- https://doi.org/10.1074/jbc.m105872200
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Site-Directed Mutagenesis of Cysteinyl and Serine Residues of Human Thromboxane A2Receptor in Insect CellsArchives of Biochemistry and Biophysics, 1996
- Mutagenic Analysis of Platelet Thromboxane Receptor CysteinesPublished by Elsevier ,1996
- Aspirin as an Antiplatelet DrugNew England Journal of Medicine, 1994
- Collaborative overview of randomised trials of antiplatelet therapy - III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patientsBMJ, 1994
- Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapyBMJ, 1994
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Modeling of human thromboxane A2 receptor and analysis of the receptor-ligand interactionJournal of Medicinal Chemistry, 1993
- Suppression of Thromboxane A2but Not of Systemic Prostacyclin by Controlled-Release AspirinNew England Journal of Medicine, 1991
- Cloning and expression of cDNA for a human thromboxane A2 receptorNature, 1991
- Clinical Implications of Prostaglandin and Thromboxane A2FormationNew England Journal of Medicine, 1988